For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Making history: Protecting vulnerable healthcare workers during COVID-19
Making history: Protecting vulnerable healthcare workers during COVID-19

Occupational health expert David McBride describes a risk assessment framework for identifying and protecting staff potentially vulnerable to COVID-19, which has been developed during an under-resourced era in occupational medicine
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
-
Glass B. Dr Thomas Ownsworth Garland, 1903-1993: New Zealand's pioneer in occupational medicine. Occup Med (Lond) 2003;53(8):507–11.
-
Bush A, Pavord I. Highlights from this issue. Thorax 2013;68(3):i.
-
Al-Shaqsi S, Gauld R, McBride D, et al. The state of healthcare disaster plans in New Zealand and the Sultanate of Oman: An international comparative analysis. Advances in Emergency Medicine 2014;758728.
-
Al-Shaqsi S, McBride D, Gauld R, et al. Are we ready? Preparedness of acute care providers for the Rugby World Cup 2011 in New Zealand. Emerg Med J 2013;30(8):611–14.
-
Al-Shaqsi S, Gauld R, Lovell S, et al. Challenges of the New Zealand healthcare disaster preparedness prior to the Canterbury earthquakes: a qualitative analysis. NZ Med J 2013;126(1371):9–18.